Stablepharma Ltd
Professor Saul Faust BMA, MBBS, FRCPCH, PhD, FHEA is a Professor of Paediatric Immunology and Infectious Diseases at the University of Southampton and Director of the NIHR Southampton Clinical Research Facility.
He is currently leading the UK National 3rd dose COVID-19 vaccine booster trial, and will be the lead advisor for the StablevaX ™ First in Human Clinical Trials.
This person is not in the org chart
This person is not in any offices
Stablepharma Ltd
An innovative Biotech, developing a wide range of reformulated thermostable and fridge free StablevaX vaccines